These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14598304)

  • 21. Role of protein kinase C-epsilon in the development of kappa-opioid receptor tolerance to U50,488H in rat ventricular myocytes.
    Zhou JJ; Bian JS; Pei JM; Wu S; Li HY; Wong TM
    Br J Pharmacol; 2002 Apr; 135(7):1675-84. PubMed ID: 11934807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kappa-opioid receptor stimulation inhibits growth of neonatal rat ventricular myocytes.
    Wang G; Wang H; Yang Y; Wong TM
    Eur J Pharmacol; 2004 Sep; 498(1-3):53-8. PubMed ID: 15363975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
    Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential properties between TRK-820 and U-50,488H on the discriminative stimulus effects in rats.
    Mori T; Nomura M; Yoshizawa K; Nagase H; Narita M; Suzuki T
    Life Sci; 2004 Oct; 75(20):2473-82. PubMed ID: 15350822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. kappa-opioid receptor stimulation inhibits cardiac hypertrophy induced by beta1-adrenoceptor stimulation in the rat.
    Shan D; Wang H; Su Y; Jing Y; Wong TM
    Eur J Pharmacol; 2007 Jan; 555(2-3):100-5. PubMed ID: 17126321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative hypotensive actions of three nonpeptide kappa opioid agonists on hippocampus of SHRs and normotensive WKY rats.
    Zhai QZ; Ingenito AJ
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):806-12. PubMed ID: 9641463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of κ-opioid receptor exerts the glucose-homeostatic effect in streptozotocin-induced diabetic mice.
    Shang Y; Guo F; Li J; Fan R; Ma X; Wang Y; Feng N; Yin Y; Jia M; Zhang S; Zhou J; Wang H; Pei J
    J Cell Biochem; 2015 Feb; 116(2):252-9. PubMed ID: 25186835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
    Takemori AE; Schwartz MM; Portoghese PS
    J Pharmacol Exp Ther; 1988 Dec; 247(3):971-4. PubMed ID: 2849679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of kappa-opioid receptor agonists in learning and memory impairment in animal models.
    Hiramatsu M; Kameyama T
    Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):595-9. PubMed ID: 9819804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor.
    Wu S; Li HY; Wong TM
    Circ Res; 1999 Jun; 84(12):1388-95. PubMed ID: 10381890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
    Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of kappa opioid receptors decreases synaptic transmission and inhibits long-term potentiation in the basolateral amygdala of the mouse.
    Huge V; Rammes G; Beyer A; Zieglgänsberger W; Azad SC
    Eur J Pain; 2009 Feb; 13(2):124-9. PubMed ID: 18439862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. κ-opioid receptor activation prevents against arrhythmias by preserving Cx43 protein via alleviation of intracellular calcium.
    Shi QX; Zhang LJ; Yao Y; Zhang QY; Wang W; Li J; Shang YL; Bi H; Zhang SM; Guo HT; Wang YM; Yu SQ; Yi DH; Bueno FR; Kaye AD; Pei JM
    Am J Ther; 2013; 20(5):493-501. PubMed ID: 23011166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
    Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generalization of NMDA-receptor antagonists to the discriminative stimulus effects of kappa-opioid receptor agonists U-50,488H, but not TRK-820 in rats.
    Mori T; Nomura M; Yoshizawa K; Nagase H; Sawaguchi T; Narita M; Suzuki T
    J Pharmacol Sci; 2006 Feb; 100(2):157-61. PubMed ID: 16474203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence.
    Suzuki S; Chuang LF; Doi RH; Bidlack JM; Chuang RY
    Int Immunopharmacol; 2001 Sep; 1(9-10):1733-42. PubMed ID: 11562065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the neuronal nicotinic receptor-mediated current by kappa opioid receptor agonists in PC12 cells.
    Oka K; Andoh T; Watanabe I; Kamiya Y; Ito H
    Pflugers Arch; 1998 Nov; 436(6):887-93. PubMed ID: 9799403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
    Li JG; Zhang F; Jin XL; Liu-Chen LY
    J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of kappa-opioid receptor stimulation in the heart and the involvement of protein kinase C.
    Bian JS; Wang HX; Zhang WM; Wong TM
    Br J Pharmacol; 1998 Jun; 124(3):600-6. PubMed ID: 9647487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contralateral, ipsilateral and bilateral treatments with the kappa-opioid receptor agonist U-50,488H in mononeuropathic rats.
    Bileviciute-Ljungar I; Spetea M
    Eur J Pharmacol; 2004 Jun; 494(2-3):139-46. PubMed ID: 15212967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.